A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
Subscribe To Our Newsletter & Stay Updated
